Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
UBS
Argus Health
Dow
Deloitte
Chubb
Daiichi Sankyo
Federal Trade Commission
Merck
McKesson

Generated: October 22, 2017

DrugPatentWatch Database Preview

Pindolol - Generic Drug Details

« Back to Dashboard

What are the generic sources for pindolol and what is the scope of pindolol patent protection?

Pindolol
is the generic ingredient in two branded drugs marketed by Idt Australia Ltd, Mylan Pharms Inc, Nostrum Labs Inc, G And W Labs Inc, Purepac Pharm, Watson Labs, Sun Pharm Inds, Zydus Pharms Usa Inc, Nostrum Labs, and Novartis, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pindolol. Five suppliers are listed for this compound.

Summary for Generic Name: pindolol

US Patents:0
Tradenames:2
Applicants:10
NDAs:15
Drug Master File Entries: see list11
Suppliers / Packagers: see list5
Bulk Api Vendors: see list42
Clinical Trials: see list11
Patent Applications: see list5,737
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pindolol at DailyMed

Pharmacology for Ingredient: pindolol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Purepac Pharm
PINDOLOL
pindolol
TABLET;ORAL074125-001Apr 28, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
PINDOLOL
pindolol
TABLET;ORAL205415-002Jan 13, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Zydus Pharms Usa Inc
PINDOLOL
pindolol
TABLET;ORAL209866-002Aug 18, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
PINDOLOL
pindolol
TABLET;ORAL074123-002Apr 17, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
G And W Labs Inc
PINDOLOL
pindolol
TABLET;ORAL073687-002Feb 26, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
Novartis
VISKEN
pindolol
TABLET;ORAL018285-001Sep 3, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Idt Australia Ltd
PINDOLOL
pindolol
TABLET;ORAL073609-001Mar 29, 1993ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
PINDOLOL
pindolol
TABLET;ORAL074019-002Sep 3, 1992ABRXNoYes► Subscribe► Subscribe► Subscribe
Nostrum Labs
PINDOLOL
pindolol
TABLET;ORAL074474-001Oct 28, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
PINDOLOL
pindolol
TABLET;ORAL074018-001Sep 24, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: pindolol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis
VISKEN
pindolol
TABLET;ORAL018285-001Sep 3, 1982► Subscribe► Subscribe
Novartis
VISKEN
pindolol
TABLET;ORAL018285-002Sep 3, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
US Army
Dow
Cantor Fitzgerald
Boehringer Ingelheim
AstraZeneca
Cerilliant
Novartis
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot